Skip to main content

Table 2 Clinical manifestations of patients with organophosphate poisoning, stratified according to diabetes mellitus status (N = 118)

From: Acute large-dose exposure to organophosphates in patients with and without diabetes mellitus: analysis of mortality rate and new-onset diabetes mellitus

Variable

Total (N = 118)

Non–diabetes mellitus (N = 109)

Diabetes mellitus (N = 9)

P

1. Cholinergic crisis

    

Cardiovascular system:

    

Systolic BP, mm Hg (mean ± SD)

116.81 ± 23.21

117.46 ± 22.98

108.89 ± 26.00

0.289

Diastolic BP, mm Hg (mean ± SD)

79.68 ± 18.24

80.30 ± 17.88

72.11 ± 21.92

0.197

Heart rate, beats/minute (mean ± SD)

102.04 ± 26.72

103.26 ± 27.75

91.43 ± 11.10

0.270

Hypotension, n (%)

27 (22.9)

24 (22.0)

3 (33.3)

0.437

Gastrointestinal system, n (%):

    

Diarrhea

35 (29.7)

35 (32.1)

0 (0.0)

0.053

Emesis

42 (35.6)

40 (36.7)

2 (22.2)

0.383

Respiratory system, n (%):

    

Shortness of breath

81 (68.6)

75 (68.8)

6 (66.7)

0.894

Bronchorrhea

72 (61.0)

66 (60.6)

6 (66.7)

0.718

Bronchospasm

67 (56.8)

61 (56.0)

6 (66.7)

0.533

Respiratory failure

61 (51.7)

55 (50.5)

6 (66.7)

0.350

Genitourinary system n (%):

    

Acute renal failure

11 (9.3)

10 (9.2)

1 (11.1)

0.848

Central nervous system n (%):

    

Seizure

10 (8.5)

8 (7.3)

2 (22.2)

0.123

Coma

23 (19.5)

21 (19.3)

2 (22.2)

0.830

2. Intermediate syndrome, n (%)

10 (8.5)

10 (9.2)

0 (0.0)

0.342

3. Delayed polyneuropathy, n (%)

3 (2.5)

3 (2.8)

0 (0.0)

0.614

  1. SD, standard deviation; BP, blood pressure.